Showing results (281-290 of 407) with videos related to

Sort By:
Pageof 41
Journal of the National Cancer Institute|December 7, 2000
Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivoR Schiff, P Reddy, M Ahotupa, et al.
Investigational New Drugs|September 18, 1998
A phase I and pharmacokinetic trial of terephthalamidine (NSC 57155) as a 120-hour continuous infusionG I Rodriguez, J G Kuhn, G Weiss, et al.
Journal of the National Cancer Institute|January 15, 2009
Effect of lapatinib on the development of estrogen receptor-negative mammary tumors in miceTracy E Strecker, Qiang Shen, Yun Zhang, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Targeting the activator protein 1 transcription factor for the prevention of estrogen receptor-negative mammary tumorsQiang Shen, Ivan P Uray, Yuxin Li, et al.
Journal of the National Cancer Institute|May 1, 2008
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapyXiaoxian Li, Michael T Lewis, Jian Huang, et al.
Oral Oncology|August 10, 2023
Phase I / II trial of metformin as a chemo-radiosensitizer in a head and neck cancer patient populationJan O Kemnade, Marcus Florez, Anita Sabichi, et al.
American Journal of Medical Genetics|July 16, 1999
Congenital anomalies and anthropometry of 42 individuals with deletions of chromosome 18qJ D Cody, P D Ghidoni, B R DuPont, et al.
Breast Cancer Research : BCR|September 24, 2010
P190B RhoGAP has pro-tumorigenic functions during MMTV-Neu mammary tumorigenesis and metastasisPeter R McHenry, James C Sears, Matthew P Herrick, et al.
Pageof 41